174
Views
56
CrossRef citations to date
0
Altmetric
Research Article

The Reformulation Regime in Drug Discovery: Revisiting Polyherbals and Property Rights in the Ayurvedic Industry

&
Pages 57-79 | Received 21 Mar 2012, Accepted 29 May 2013, Published online: 01 Oct 2020

References

  • Abélès Marc (2008). Anthropologie de la globalisation. Paris: Payot.
  • Anuradha R. V. , Taneja Bansuri , and Kothari Ashish (2001). Experiences with Biodiversity Policy-Making and Community Registers in India. London: International Institute for Environment and Development.
  • Banerjee Madhulika (2008). Ayurveda in Modern India: Standardization and Pharmaceuticalization. In Modern and Global Ayurveda: Pluralism and Paradigms, edited by Wujastik Dagmar and Smith Frederick , 201–14. Albany: State University of New York Press.
  • Banerjee Madhulika (2009). Power, Knowledge, Medicine: Ayurvedic Pharmaceuticals at Home and in the World. Hyderabad: Orient Blackswan.
  • Barton John H. (2007). New Trends in Technology Transfer: Implications for National and International Policy. ICTSD Issue Paper no. 18. Geneva: International Centre for Trade and Sustainable Development.
  • Baviskar Amita (2000). Claims to Knowledge, Claims to Control: Environmental Conflict in the Great Himalayan National Park, India. In Indigenous Environmental Knowledge and Its Transformations: Critical Anthropological Perspectives, edited by Ellen Roy Parkes Peter Bicker Alan , 101–201. Amsterdam: Harwood Academic.
  • Bertin Gilles , and Wyatt Sally (1986). Multinationales et propriété intellectuelle: Le contrôle de la technologie mondiale. Paris: Presses Universitaires de France.
  • Bode Maarten (2008). Taking Traditional Medicine to the Market: The Modern Image of the Ayurvedic and Unani Industry 1980–2000. Hyderabad: Orient Longman.
  • Calvert Jane , and Joly Pierre-Benoît (2011). How Did the Gene Become a Chemical Compound? The Ontology of the Gene and the Patenting of DNA. Social Science Information 50, no. 2: 157–77.
  • Cassier Maurice (2008). Brevets pharmaceutiques et accès aux médicaments: Inventer de nouvelles solutions. Technology Review (French ed.) 6: 58–63.
  • Cassier Maurice , and Sinding Christiane (2008). Patenting for the Public Interest. Administration of Insulin Patents by the University of Toronto. History and Technology 24: 153–71.
  • Chauveau Sophie (1999). L'invention pharmaceutique: La pharmacie française entre l'état et la société au XXe siècle. Paris: Les Empêcheurs.
  • Challa Jagannadham , and Kalla Jagdeesh C. (1995). World Trade Agreement and Trade-Related Aspects of Intellectual Property Rights: Relevance to Indian Agriculture. Commonwealth Agricultural Digest 4: 4–20.
  • Clarke Adele Mamo Laura Ruth Fosket Jennifer Shim Janet , eds. (2010). Biomedicalization: Technoscience, Health, and Illness in the United States. Durham, NC: Duke University Press.
  • Croizier Ralph (1968). Traditional Medicine in Modern China. Cambridge, MA: Harvard University Press.
  • Cullet Philippe , and Raja Jawahar (2004). Intellectual Property Rights and Biodiversity Management: The Case of India. Global Environmental Politics 4, no. 1: 97–114.
  • Dos Santos José , and Fleurentin Jacques (1990). L'ethnopharmacologie: Une approche pluridisciplinaire. In Ethnopharmacologie, sources, méthodes, objectifs, edited by Cabalion Pierre Dos Santos José Fleurentin Jacques Mazars Guy Younos Chafique , 26–40. Paris: Editions de l'ORSTOM—Société Française d'Ethnopharmacologie.
  • Dutfield Graham (1999). Protecting and Revitalising Traditional Ecological Knowledge: Intellectual Property Rights and Community Knowledge Databases in India. In Intellectual Property Aspects of Ethnobiology, edited by Blackeney Michael , 101–22. London: Sweet and Maxwell.
  • EIRI (Engineers India Research Institute) (2002). Handbook of Ayurvedic Medicines with Formulations. Delhi: Engineers India Research Institute.
  • Etkin Nina (1996). Ethnopharmacology: The Conjunction of Medical Ethnography and the Biology of Therapeutic Action. In Medical Anthropology: Contemporary Theory and Method, edited by Sargent Carolyn F. and Johnson Thomas M. , 151–63. Westport, CT: Praeger.
  • Ganguly, Ritika (2012). Making “Sense” inside the Lab: Ayurvedic Experiments with Sensory Analyses of Rasa. Paper presented at the “Innovating from the South: Production, Invention and Appropriation of Pharmaceutical Knowledge in Brazil and India” colloquium, Rio de Janeiro, 5–8 March.
  • Gaudillière Jean-Paul (2005). Better Prepared than Synthesized: Adolf Butenandt, Schering AG and the Transformation of Sex Steroids into Drugs. Studies in History and Philosophy of the Biological and the Biomedical Sciences 36, no. 4: 612–44.
  • Gaudillière Jean-Paul (2010). Une marchandise scientifique? Savoirs, industrie et régulation du médicament dans l'Allemagne des années trente. Annales—Histoire, Sciences Sociales 65, no. 1: 89–120.
  • Gaudillière, Jean-Paul (2011). Industrializing Medicinal Plant Preparations: Appropriation and Protection at the World Intellectual Property Organization, the European Patent Office and the Traditional Knowledge Digital Library. Paper presented at the “Plants, Animals, and Ownership Innovation and Intellectual Property Protection in Living Organisms since the Eighteenth Century” international workshop, Yale University, 3–5 June.
  • Gaudillière, Jean-Paul (2012). Plants, the Practices of Reformulation and the Construction of Ayurvedic Markets: The Trajectory of Jeevani. Paper presented at the “Innovating from the South: Production, Invention and Appropriation of Pharmaceutical Knowledge in Brazil and India” colloquium, Rio de Janeiro, 5–8 March.
  • Gaudillière Jean-Paul Hess Volker , eds. (2012). Ways of Regulating Drugs in the Nineteenth and Twentieth Centuries. Basingstoke, UK: Palgrave Macmillan.
  • Godfraind Théophile , and Ardaillou Raymond (2007). Approche classique et innovation pour la recherche de nouveaux medicaments. Bulletin de l'Académie Nationale de Médecine 191, no. 4–5: 715–26.
  • Hacking Ian (1995). The Looping Effect of Human Kinds. In Causal Cognition: A Multidisciplinary Debate, edited by Sperber Dan Premack David Premack Ann James , 351–94. New York: Oxford University Press.
  • Hobsbawm Eric , and Ranger Terence (2003). The Invention of Tradition. Cambridge: Cambridge University Press.
  • Hsu Elisabeth (2009). Chinese Propriety Medicines: An Alternative Modernity? The Case of the Anti-malarial Substance Artemisinin in East Africa. Medical Anthropology 28, no. 2: 111–40.
  • Janes Craig (1995). The Transformations of Tibetan Medicine. Medical Anthropology Quarterly 9, no. 1: 6–39.
  • Knauft Bruce (2002). Critically Modern: An Introduction. In Critically Modern: Alternatives, Alterities, Anthropologies, edited by Knauft Bruce M. , 1–54. Bloomington: Indiana University Press.
  • Lanjouw Jean O. (1997). The Introduction of Pharmaceutical Products Patents in India: Heartless Exploitation of the Poor and Suffering? Center Discussion Paper no. 775. New Haven, CT: Economic Growth Center, Yale University.
  • Lei Sean H. (1999). From changshan to a New Anti-malarial Drug: Re-networking Chinese Drugs and Excluding Chinese Doctors. Social Studies of Science 29, no. 3: 323–58.
  • Lesch John E. (1993). Chemistry and Biomedicine in an Industrial Setting: The Invention of the Sulfa Drugs. In Chemical Sciences in the Modern World, edited by Mauskopf Seymour H. , 158–215. Philadelphia: University of Pennsylvania Press.
  • Lesch John E (2007). The First Miracle Drugs: How the Sulfa Drugs Transformed Medicine. Oxford: Oxford University Press.
  • Leslie Charles (1989). Indigenous Pharmaceuticals, the Capitalist World System, and Civilization. Kroeber Anthropological Society Papers 69–70: 23–31.
  • Löwy Ilana , and Gaudillière Jean-Paul (2006). Médicalisation de la ménopause, mouvements pour la santé des femmes et controverses sur les thérapies hormonale. Nouvelles Questions Féministes 25, no. 2: 48–65.
  • Madhavan Harilal (2009). Commercialising Traditional Medicine: Ayurvedic Manufacturing in Kerala. Economic and Political Weekly 44, no. 16: 44–51.
  • Madhavan, Harilal (2011). Innovations, Bio-enterprises and Well-Being: Kani Traditional Knowledge and Its Uses. Presentation at the “Mondialisation de la santé et du médicament” seminar, École des Hautes Études en Sciences Sociales, Paris, 19 October.
  • Millard Colin (2008). The Integration of Tibetan Medicine in the United Kingdom: The Clinics of the Tara Institute of Medicine. In Tibetan Medicine in the Contemporary World: Global Politics of Medical Knowledge and Practice, edited by Pordié Laurent , 189–214. London and New York: Routledge.
  • Mueller Janice M. (2007). The Tiger Awakens: The Tumultuous Transformations of India's Patent System and the Rise of Indian Pharmaceutical Innovation. University of Pittsburgh Law Review 68, no. 3: 491–641.
  • Naraindas Harish (2006). Of Spineless Babies and Folic Acid: Evidence and Efficacy in Biomedicine and Ayurvedic Medicine. Social Science and Medicine 62, no. 11: 2658–69.
  • NIIR (National Institute of Industrial Research) (2003). Compendium of Medicinal Plants. New Delhi: NIIR.
  • OMS (Organisation mondiale de la santé) (2002). Stratégie de l'OMS pour la médecine traditionnelle pour 2002–2005. Geneva: OMS.
  • Pati Biswamoy , and Harrison Mark (2001). Health, Medicine and Empire: Perspectives on Colonial India. Hyderabad: Orient Longman.
  • Patwardhan Bhushan (2005). Ethnopharmacology and Drug Discovery. Journal of Ethnopharmacology 100: 50–52.
  • Patwardhan Bhushan , and Vaidya Ashok D. B. (2010). Natural Product Discovery: Accelerating the Clinical Candidate Development Using Reverse Pharmacology Approaches. Indian Journal of Experimental Biology 48: 220–27.
  • Patwardhan Bhushan , Vaidya Ashok D. B. , and Chorghade Mukund (2004). Ayurveda and Natural Products Drug Discovery. Current Science 86: 789–99.
  • Patwardhan Bhushan , Vaidya Ashok D. B. , Chorghade Mukund , and Joshi Swati P. (2008). Reverse Pharmacology and Systems Approaches for Drug Discovery and Development. Current Bioactive Compounds 4, no. 4: 1–12.
  • Patwardhan Bhushan , and Mashelkar Raghunath Anant (2009). Traditional Medicine-Inspired Approaches to Drug Discovery: Can Ayurveda Show the Way Forward? Drug Discovery Today 14, no. 15–16: 804–11.
  • Pestre Dominique (2003). Science, argent et politique: Un essai d'interprétation. Paris: INRA.
  • Pordié Laurent (2008a). Tibetan Medicine Today: Neo-traditionalism as an Analytical Lens and a Political Tool. In Tibetan Medicine in the Contemporary World. Global Politics of Medical Knowledge and Practice, edited by Pordié Laurent , 3–32. London and New York: Routledge.
  • Pordié Laurent (2008b). Hijacking Intellectual Property Rights: Power and Identities in the Himalayas. In Tibetan Medicine in the Contemporary World: Global Politics of Medical Knowledge and Practice, edited by Pordié Laurent , 132–59. London and New York: Routledge.
  • Pordié Laurent (2010a). The Politics of Therapeutic Evaluation in Asian Medicine. Economic and Political Weekly 45, no. 18: 57–64.
  • Pordié Laurent (2010b). Pharmacopée “traditionnelle. In Dictionnaire de l'Inde contemporaine, edited by Landy Frédéric , 402–4. Paris: Colin.
  • Pordié Laurent (2011). Savoirs thérapeutiques asiatiques et globalization. Revue d'Anthropologie des Connaissances 5, no. 1: 1–12.
  • Pordié Laurent , and Simon Emmanuelle (2013). Les nouveaux guérisseurs: Biographies de thérapeutes au temps de la globalization. Paris: Editions de l'École des Hautes Études en Sciences Sociales.
  • Reddy Sita (2002). Asian Medicine in America: The Ayurvedic Case. Annals of the American Academy of Political and Social Science 583, no. 1: 97–121.
  • Sahu Sunil (1998). Technology Transfer, Dependence, and Self-Reliant Development in the Third World. London: Praeger.
  • Scherer Frédéric (2000). Le système des brevets et l'innovation dans le domaine pharmaceutique. Revue Internationale de Droit Economique 1: 109–24.
  • Scherer Frédéric , and Watal Jayashree (2002). Post-TRIPS Options for Access to Patented Medicines in Developing Nations. Journal of International Economic Law 5, no. 4: 913–39.
  • Sébastia Brigitte (2011). Le passage des frontières de médecines pas très douces: Prévenir l'innocuité ou préserver l'authenticité ? Le problème des formulations iatrochimiques dans la médication siddha. Revue d'Anthropologie des Connaissances 5, no. 1: 71–98.
  • Subramanian, Arvind (1999). Intellectual Property Post-Seattle: Challenges for India as User and Creator. Paper presented at the Workshop on South Asia and the WTO, New Delhi, 20–21 December.
  • Swann John P. (1988). Academic Scientists and the Pharmaceutical Industry. Cooperation Research in Twentieth-Century America. Baltimore: Johns Hopkins University Press.
  • Ulbricht Cartherine , Basch Ethan , Szapary Philippe , Hammerness Paul , Axentsev Serguei , Boon Heather , Kroll David , Garraway Levi , Vora Mamta , and Woods Jen (2005). Guggul for Hyperlipidemia: A Review by the Natural Standard Research Collaboration. Complementary Therapeutic Medicine 13, no. 4: 279–90.
  • Vaidya Ashok D. B. (2006). Reverse Pharmacological Correlates of Ayurvedic Drug Action. Indian Journal of Pharmacology 38, no. 5: 311–15.
  • Varier Raghava M. R. (2002). The Rediscovery of Ayurveda: The Story of Arya Vaidya Sala. Kottakal, New Delhi: Viking.
  • Ved D. K. , and Goraya G. S. (2008). Demand and Supply of Medicinal Plants in India. Delhi: National Medicinal Plant Board.
  • WHO (2000). General Guidelines for Methodologies on Research and Evaluation of Traditional Medicine. WHO/EDM/TRM/2000.1. Geneva: WHO.
  • WIPO Secretariat (2004). Protection of Traditional Knowledge: Overview of Policy Objectives and Principles. WIPO/GRTKF/IC/7/5. Geneva: WHO.
  • Zimmermann Francis (1982). La jungle et le fumet des viandes: Un thème écologique dans la médecine hindoue. Paris: Gallimard—Le Seuil, Hautes Études.
  • Zimmermann Francis (1995). Généalogie des médecines douces: De l'Inde à l'Occident. Paris: Presses Universitaires de France.
  • Zimmermann Francis (2011). Du phlegmon à l'azadirachtine: Représentations indiennes des maladies et bioprospection. In Maladie et santé selon les sociétés et les cultures, edited by Godelier Maurice , 53–73. Paris: Presses Universitaires de France.
  • Zimmermann, Francis (2012). Inconspicuous Turmeric: Disguised Saliencies in the Hybrid Models of Pharmaceuticals. Paper presented at the “Innovating from the South: Production, Invention and Appropriation of Pharmaceutical Knowledge in Brazil and India” colloquium, Rio de Janeiro, 5–8 March.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.